ArticleInvestigational new drugs2025

Multicenter retrospective study of selpercatinib treatment for advanced or recurrent RET fusion-positive non-small cell lung cancer in Japan.

Yasuhiro Mihashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.